Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
NCT06073886
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to investigate a new treatment for chronic symptoms after concussion or mild traumatic brain injury in people aged 18-65 years old. Chronic symptoms could include dizziness, headache, fatigue, brain fog, memory difficulty, sleep disruption, irritability, or anxiety that occurred or worsened after the injury. These symptoms can interfere with daily functioning, causing difficulty returning to physical activity, work, or school. Previous concussion therapies have not been personalized nor involved direct treatments to the brain itself.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Post-Concussion Syndrome
- Concussion, Brain
- Mild Traumatic Brain Injury
- Head Injury
- Headache
- Dizziness
- Cognitive Symptom
- Dysautonomia
- Anxiety
- Irritability; Syndrome
- Depression
- Post-traumatic Stress Disorder
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of California, Los Angeles
- Last updated on ClinicalTrials.gov
- February 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- UCLA · Westwood, Los Angeles, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.